BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible for all. Our patent-pending QCT molecular counter platform is the only technology platform that can accurately count the DNA molecules using Next Generation Sequencing

The First and Only Carrier Screen with Reflex Single-gene NIPT

Our first commercial product, UNITY, is the single-gene NIPT supported carrier screen for cystic fibrosis, spinal muscular atrophy, sickle cell disease, and alpha- and beta-thalassemia. Visit our product site to learn more.